The Mast Cell: A Potential Therapeutic Target in Myocardial Infarction

ISSN： 1567-2697

Source： Drug Design Reviews - Online, Vol.2, Iss.3, 2005-05, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrophage Polarization as a Therapeutic Target in Myocardial Infarction

Current Drug Targets, Vol. 19, Iss. 6, 2018-04 ,pp. : 651-662

Bentham Science Publishers

Access to resources Recommend Favorite

Fibrosis as a Therapeutic Target Post-Myocardial Infarction

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 477-487

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Monteplase in Acute Myocardial Infarction

By Inoue Teruo

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 4, 2005-01 ,pp. : 225-231

Adis International

Access to resources Recommend Favorite

MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 2, 2007-06 ,pp. : 101-107

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

By Ferguson James J Vaisman Dan

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1965-1976

Informa Healthcare

Access to resources Recommend Favorite